rs104893898
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000296684.10(NDUFS4):c.316C>T(p.Arg106Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,482 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000296684.10 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDUFS4 | NM_002495.4 | c.316C>T | p.Arg106Ter | stop_gained | 3/5 | ENST00000296684.10 | NP_002486.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NDUFS4 | ENST00000296684.10 | c.316C>T | p.Arg106Ter | stop_gained | 3/5 | 1 | NM_002495.4 | ENSP00000296684 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251396Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135862
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461482Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727070
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Mitochondrial complex I deficiency, nuclear type 1 Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 20, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Centogene AG - the Rare Disease Company | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 18, 2000 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | - | This nonsense variant found in exon 3 of 5 is predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has been previously reported as a homozygous change in patients with mitochondrial complex I deficiency (PMID: 10944442). Functional studies have shown the presence of this variant results in a reduction of complex I enzymatic activity in skeletal muscle (PMID: 10944442). The c.316C>T (p.Arg106Ter) variant is present in the heterozygous state in the gnomAD population database at a frequency of 0.0004 % (1/251396) and is absent in the homozygous state, thus is presumed to be rare. Based on the available evidence, the c.316C>T (p.Arg106Ter) variant is classified as Pathogenic. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 19, 2023 | This sequence change creates a premature translational stop signal (p.Arg106*) in the NDUFS4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NDUFS4 are known to be pathogenic (PMID: 10944442, 16213125). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with mitochondrial complex I deficiency (PMID: 10944442). ClinVar contains an entry for this variant (Variation ID: 6889). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 28, 2022 | Functional studies conducted in patient cells demonstrate R106* exhibits morphogenesis defects as neurite outgrowth was decreased in immature neurons expressing the variant compared to wild type neural progenitor cells (Inak et al., 2021); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 22033105, 10944442, 32860008, 33771987) - |
Leigh syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 31, 2022 | Variant summary: NDUFS4 c.316C>T (p.Arg106X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4e-06 in 251396 control chromosomes (gnomAD). c.316C>T has been reported in the literature in multiple individuals affected with NADH-ubiquinone oxidoreductase (complex I) deficiency or combined complex I and III deficiency (Budde_2000, Voets_2012, Haack_2012). These data indicate that the variant is very likely to be associated with disease. In addition, this variant results in impaired cytosolic Ca2+ handling in complex I-deficient fibroblasts (Visch_2004, Voets_2012). One ClinVar submitter (evaluation after 2014) cites the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Mitochondrial complex I deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München | Nov 15, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at